UBS reduced its holdings in SSY GROUP (02005) by 37,200 shares at a price of approximately HK$3.24 per share.
On February 21, UBS reduced its stake in Sino Biopharmaceutical (02005) by 372,000 shares, with a price of HK$3.2439 per share.
According to the latest data from the Hong Kong Stock Exchange, on February 21st, UBS reduced its holdings of SSY GROUP (02005) by 372,000 shares, with a price of 3.2439 Hong Kong dollars per share, totaling approximately 1.2067 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 265 million shares, with a new shareholding percentage of 8.98%.
Related Articles

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.
Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


